Article Sidebar

PDF
Date Published: 19/07/2023
Online Published: 19/07/2023
Abstract Views: 2911
Views PDF: 4327
DOI: https://doi.org/10.60137/tmhvn.v68i60.24
Issue
Vol. 68 No. 60
Section
Articles
How to Cite
Dang, X. V., Ngo, T. B., Khieu , H. T., Chu , T. H., & Nguyen, T. T. U. (2023). OVERVIEW OF TREATMENTS FOR MENIERE’S DISEASE. Vietnam Journal of Otorhinolaryngology - Head and Neck Surgery, 68(60), 15-22. https://doi.org/10.60137/tmhvn.v68i60.24

OVERVIEW OF TREATMENTS FOR MENIERE'S DISEASE

Xuan Vinh Dang , Thanh Binh Ngo, Huu Thanh Khieu , Thi Hong Chu , Thi To Uyen Nguyen

Main Article Content

Abstract

Objectives: To review the overview of treatment methods for Ménière's disease. Study design: Scoping review. Methods: Using database from Pubmed website, Hanoi Medical University library and manual search (from January 2016 to December 2021). Selection criteria were studies on the treatment of Meniere's disease). Result: we found 2326 articles from search keywords with 36 articles matching the selection criteria. 36 articles involving 2426 patients with 11 different treatments were included in the analysis. We analyzed the process and treatment results of the aforementioned methods. Conclusion: Most of the treatments for Meniere's disease are effective in controlling vertigo with varying degrees.
The ability to recover a better hearing after treatment of such methods is not clear.

Keywords

Ménière Disease (MD), Lifestyle change, Dietary Restriction, Diuretic, Betahistine, Intratympanic (IT), Surgery

Article Details

References

1. Basura GJ, Adams ME, Monfared A, et al. Clin- ical Practice Guideline: Ménières Disease. Otolar- ỵngolHead Neck Surg. 2020;162(2_suppl): Sl-S55. doi: 10.1177/0194599820909438
2. Iwasaki S, Shojaku H, Murofushi T, et al. Diagnostic and therapeutic strategies for Meniere’s disease of the Japan Society for Equilibrium Research. Aw- n's Nasus Larynx. 2021;48(1):15- 22. doi:10.1016/j. anl.2020.10.009
3. Kitahara T, Okamoto H, Fukushima M, et al. A Two-Year Randomized Trial of Interventions to Decrease Stress Hormone Vasopressin Production in Patients with Meniere’s Disease-A Pilot Study. PloS One. 2016;11(6): e0158309.
4. Adrion C, Fischer CS, Wagner J, Giirkov R, Mans- mann U, Strupp M.
Efficacy and safety of betahistine treatment in patients with Meniere’s disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). BMJ. Published online January 21, 2016:h6816. doi:10.1136/bmj.h6816
5. Oztiirk K, Ata N. Intratympanic mixture gen- tamicin and dexamethasone versus dexameth- asone for unilateral Meniere’s disease. Am J Otolaryngol. 2019;40(5):711-714. doi:10.1016/j.am- joto.2019.06.008
6. Naples JG, Henry L, Brant JA, Eliades SJ, Rucken- stein MJ. Intratympanic Therapies in Meniere Disease: Evaluation of Outcomes and Early Ver- tigo Control: Intratympanic Therapy in Meniere Disease. The Laryngoscope. 2019;129(1):216-221. doi:10.1002/lary.27392
7. Higashi-Shingai K, Imai T, Okumura T, et al. Change in endolymphatic hydrops 2 years after endolymphatic sac surgery evaluated by MRI. Auris Nasus Larynx. 2019; 46(3):335-345. doi: 10.1016/j. anl.2018.10.011.